{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:42:41Z","timestamp":1794508961110,"version":"4.9.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T00:00:00Z","timestamp":1542585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31370896"],"award-info":[{"award-number":["31370896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31670907"],"award-info":[{"award-number":["31670907"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471585"],"award-info":[{"award-number":["81471585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.biopha.2018.11.069","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T00:03:21Z","timestamp":1543795401000},"page":"285-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development"],"prefix":"10.1016","volume":"110","author":[{"given":"Ziqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoshan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2018.11.069_bib0005","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2337\/diabetes.53.5.1243","article-title":"Adipose tissue expression of the lipid droplet-associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-gamma","volume":"53","author":"Dalen","year":"2004","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.biopha.2018.11.069_bib0010","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.biopha.2018.11.069_bib0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0020","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0025","first-page":"161","article-title":"Carotenoids and non-alcoholic fatty liver disease","volume":"4","author":"Yilmaz","year":"2015","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"10","key":"10.1016\/j.biopha.2018.11.069_bib0030","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.TP.0000436723.59879.01","article-title":"Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation","volume":"96","author":"Kemmer","year":"2013","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.biopha.2018.11.069_bib0035","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2018.11.069_bib0040","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMe0810291","article-title":"Weight-loss diets for the prevention and treatment of obesity","volume":"360","author":"Katan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2018.11.069_bib0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1055\/s-2000-11202","article-title":"Improvement of phase I drug metabolism with Schisandra chinensis against CCl4 hepatotoxicity in a rat model","volume":"66","author":"Zhu","year":"2000","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.11.069_bib0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jep.2010.06.038","article-title":"Integral pharmacokinetics of multiple lignan components in normal, CCl4-induced hepatic injury and hepatoprotective agents pretreated rats and correlations with hepatic injury biomarkers","volume":"131","author":"Xie","year":"2010","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2018.11.069_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jep.2008.04.020","article-title":"Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine","volume":"118","author":"Panossian","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2018.11.069_bib0060","first-page":"985257","article-title":"Targeted metabolomics of serum acylcarnitines evaluates hepatoprotective effect of Wuzhi tablet (Schisandra sphenanthera extract) against acute acetaminophen toxicity","volume":"2013","author":"Bi","year":"2013","journal-title":"Evid. Complement. Alternat. Med."},{"issue":"12","key":"10.1016\/j.biopha.2018.11.069_bib0065","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1124\/dmd.114.059535","article-title":"Wuzhi tablet (Schisandra sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p53\/p21 pathways","volume":"42","author":"Fan","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.biopha.2018.11.069_bib0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/kfu216","article-title":"Schisandrol B protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of liver regeneration","volume":"143","author":"Jiang","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/aps.2015.120","article-title":"Schisandrol B protects against acetaminophen-induced acute hepatotoxicity in mice via activation of the NRF2\/ARE signaling pathway","volume":"37","author":"Jiang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.biopha.2018.11.069_bib0080","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1124\/dmd.112.050302","article-title":"Effects of traditional chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats","volume":"41","author":"Wei","year":"2013","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/dmd.114.062067","article-title":"Therapeutic efficacy of Wuzhi tablet (Schisandra sphenanthera extract) on acetaminophen-induced hepatotoxicity through a mechanism distinct from N-acetylcysteine","volume":"43","author":"Fan","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.biopha.2018.11.069_bib0090","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0095","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biopha.2018.11.069_bib0100","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-alpha and -delta, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.10.023","article-title":"PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis","volume":"66","author":"Mukhopadhyay","year":"2017","journal-title":"J. Hepatol."},{"issue":"45","key":"10.1016\/j.biopha.2018.11.069_bib0110","doi-asserted-by":"crossref","first-page":"29577","DOI":"10.1074\/jbc.273.45.29577","article-title":"Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis","volume":"273","author":"Costet","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2018.11.069_bib0115","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/hep.27686","article-title":"Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms","volume":"61","author":"Mukhopadhyay","year":"2015","journal-title":"Hepatology"},{"issue":"7477","key":"10.1016\/j.biopha.2018.11.069_bib0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature."},{"issue":"9173","key":"10.1016\/j.biopha.2018.11.069_bib0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(98)10364-1","article-title":"Medical significance of peroxisome proliferator-activated receptors","volume":"354","author":"Vamecq","year":"1999","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.biopha.2018.11.069_bib0130","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.27297","article-title":"The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice","volume":"60","author":"Pawlak","year":"2014","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.biopha.2018.11.069_bib0135","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1073\/pnas.91.23.11012","article-title":"The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression","volume":"91","author":"Gulick","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.11.069_bib0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.plipres.2013.12.001","article-title":"Regulation of energy metabolism by long-chain fatty acids","volume":"53","author":"Nakamura","year":"2014","journal-title":"Prog. Lipid Res."},{"issue":"34","key":"10.1016\/j.biopha.2018.11.069_bib0145","doi-asserted-by":"crossref","first-page":"12082","DOI":"10.3748\/wjg.v20.i34.12082","article-title":"Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic","volume":"20","author":"Hassan","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2018.11.069_bib0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.taap.2011.04.005","article-title":"Comparative gene expression profiles induced by PPARgamma and PPARalpha\/gamma agonists in rat hepatocytes","volume":"254","author":"Rogue","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2018.11.069_bib0155","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.3390\/ijms16023831","article-title":"Fatty acid signaling: the new function of intracellular lipases","volume":"16","author":"Papackova","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2018.11.069_bib0160","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.101.11.1311","article-title":"Expression and function of PPARgamma in rat and human vascular smooth muscle cells","volume":"101","author":"Law","year":"2000","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.biopha.2018.11.069_bib0165","doi-asserted-by":"crossref","first-page":"16710","DOI":"10.1074\/jbc.273.27.16710","article-title":"Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner","volume":"273","author":"Motojima","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2018.11.069_bib0170","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbrc.2007.10.057","article-title":"Selective modulation of promoter recruitment and transcriptional activity of PPARgamma","volume":"364","author":"Sears","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0180","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.4238\/2014.August.28.2","article-title":"PPAR-gamma agonist pioglitazone affects rat gouty arthritis by regulating cytokines","volume":"13","author":"Wang","year":"2014","journal-title":"Genet. Mol. Res."},{"issue":"11","key":"10.1016\/j.biopha.2018.11.069_bib0185","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/jcpe.12146","article-title":"Metabolic syndrome and gingival inflammation in Caucasian children with a family history of obesity","volume":"40","author":"Ka","year":"2013","journal-title":"J. Clin. Periodontol."},{"issue":"8","key":"10.1016\/j.biopha.2018.11.069_bib0190","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/ATVBAHA.111.241869","article-title":"Metabolic syndrome, insulin resistance, and roles of inflammation--mechanisms and therapeutic targets","volume":"32","author":"Romeo","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0195","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.22724","article-title":"Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network","volume":"49","author":"Brunt","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2018.11.069_bib0200","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.biopha.2018.11.069_bib0205","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2018.11.069_bib0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2018.11.069_bib0215","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2018.11.069_bib0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2016.03.032","article-title":"Schisantherin A suppresses interleukin-1beta-induced inflammation in human chondrocytes via inhibition of NF-kappaB and MAPKs activation","volume":"780","author":"Liao","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2018.11.069_bib0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10753-009-9166-7","article-title":"Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells","volume":"33","author":"Ci","year":"2010","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2018.11.069_bib0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2018.11.069_bib0235","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1084\/jem.20082771","article-title":"The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity","volume":"206","author":"Klotz","year":"2009","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.11.069_bib0240","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/ATVBAHA.107.149815","article-title":"Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells","volume":"28","author":"Fan","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biopha.2018.11.069_bib0245","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","article-title":"Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease","volume":"71","author":"Pisanu","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"115","key":"10.1016\/j.biopha.2018.11.069_bib0250","article-title":"Promoter methylation status and expression of PPAR-gamma gene are associated with prognosis of acute-on-chronic hepatitis B liver failure","volume":"7","author":"Zhao","year":"2015","journal-title":"Clin. Epigenet."},{"issue":"1","key":"10.1016\/j.biopha.2018.11.069_bib0255","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.29129","article-title":"Inflammation is independent of steatosis in a murine model of steatohepatitis","volume":"66","author":"Wang","year":"2017","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.biopha.2018.11.069_bib0260","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1182\/blood-2008-09-181255","article-title":"Reduction of T cell-derived ghrelin enhances proinflammatory cytokine expression: implications for age-associated increases in inflammation","volume":"113","author":"Dixit","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2018.11.069_bib0265","doi-asserted-by":"crossref","DOI":"10.1126\/stke.11pe1","article-title":"Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation","volume":"1","author":"Natoli","year":"2008","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.biopha.2018.11.069_bib0270","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.3390\/biom5043087","article-title":"Transcriptional activation of inflammatory genes: mechanistic insight into selectivity and diversity","volume":"5","author":"Ahmed","year":"2015","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.biopha.2018.11.069_bib0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2007.09.016","article-title":"Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation","volume":"41","author":"Li","year":"2008","journal-title":"Cytokine"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221832081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333221832081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T21:28:05Z","timestamp":1764106085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333221832081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":55,"alternative-id":["S075333221832081X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.11.069","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.11.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}